Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | TSHR | P16473 | 2/20 | 0.78 |
| ▸ | BLM | P54132 | 2/20 | 0.78 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | MPO | P05164 | 1/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | APAF1 | O14727 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | HTR1A | P08908 | 2/20 | 0.55 |
| ▸ | HTR2A | P28223 | 2/20 | 0.55 |
| ▸ | HTR2C | P28335 | 2/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.55 |
| ▸ | HTR7 | P34969 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tryptophan SCHEMBL1981758 | 0.99 | KMT2A (0.80) | KMT2AKDM4EMAPTLMNATSHR | |
| D-Tryptophan SCHEMBL16390702 | 0.99 | KMT2A (0.80) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL1981755 | 0.99 | KMT2A (0.80) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL21179136 | 0.98 | KMT2A (0.78) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL28996529 | 0.92 | KDM4E (0.70) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL10481608 | 0.90 | KDM4E (0.67) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL22089471 | 0.90 | KDM4E (0.67) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL10481609 | 0.90 | KDM4E (0.67) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL29733043 | 0.90 | KMT2A (0.97) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL25388544 | 0.89 | KMT2A (0.65) | KMT2AKDM4EMAPTLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10696954-B2 | Hybrid peroxidases with enhanced activity and stability | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-06-30 | — | — | US | disclosed |
| EP-2435060-B1 | OCCIDIOFUNGIN, A UNIQUE ANTIFUNGAL GLYCOPEPTIDE PRODUCED BY A STRAIN OF BURKHOLDERIA CONTAMINANS | UNIV MISSISSIPPI STATE (US) | 2019-08-28 | — | — | EP | disclosed |
| US-20190241875-A1 | HYBRID PEROXIDASES WITH ENHANCED ACTIVITY AND STABILITY | UNITED STATES DEPARTMENT OF ENERGY | 2019-08-08 | — | — | US | disclosed |
| US-10092622-B2 | Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans | MISSISSIPPI STATE UNIVERSITY (US) | 2018-10-09 | — | — | US | disclosed |
| US-20180085452-A1 | MATRIX-EMBEDDED TOLERANCE-PROMOTING ADJUVANTS FOR SUBCUTANEOUS IMMUNOTHERAPY | LUXEMBOURG INSTITUTE OF HEALTH (LU) | 2018-03-29 | — | — | US | disclosed |
| CN-107827956-A | A kind of active ring octapeptide Reniochalistatin E and the like synthetic method | 暨南大学 | 2018-03-23 | — | — | CN | disclosed |
| EP-3251662-A1 | MATRIX-EMBEDDED TOLERANCE-PROMOTION ADJUVANTS FOR SUBCUTANEOUS IMMUNOTHERAPY | Tolerogenics S.à.r.l. (LU) | 2017-12-06 | — | — | EP | disclosed |
| US-20160338955-A1 | ANTIGEN-SPECIFIC IMMUNOTHERAPY USING TOLERIZING LIPOSOMES | PLS-DESIGN GMBH (DE) | 2016-11-24 | — | — | US | disclosed |
| EP-3095440-A1 | ANTIGEN-SPECIFIC IMMUNOTHERAPY USING TOLERIZING LIPOSOMES | PLS-Design GmbH (DE) | 2016-11-23 | — | — | EP | disclosed |
| US-20160271257-A1 | Low Molecular Weight Immune-Modulators As Adjuvants for Specific Immunotherapy | PLS DESIGN GMBH (DE) | 2016-09-22 | — | — | US | disclosed |
| US-20160008423-A1 | Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans | MISSISSIPPI STATE UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2016-01-14 | — | — | US | disclosed |
| WO-2014198420-A1 | LOW MOLECULAR WEIGHT IMMUNE-MODULATORS AS ADJUVANTS FOR SPECIFIC IMMUNOTHERAPY | PLS-DESIGN GMBH (DE) | 2014-12-18 | — | — | WO | disclosed |
| EP-2813242-A1 | Low molecular weight immune-modulators as adjuvants for specific immunotherapy | PLS-Design GmbH (DE) | 2014-12-17 | — | — | EP | disclosed |
| CN-102448481-A | Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans | UNIV MISSISSIPPI STATE | 2012-05-09 | — | — | CN | disclosed |
| EP-2435060-A1 | OCCIDIOFUNGIN, A UNIQUE ANTIFUNGAL GLYCOPEPTIDE PRODUCED BY A STRAIN OF BURKHOLDERIA CONTAMINANS | Mississippi State University (US) | 2012-04-04 | — | — | EP | disclosed |
| US-20110136729-A1 | Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans | MISSISSIPPI STATE UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2011-06-09 | — | — | US | disclosed |
| WO-2010138173-A1 | OCCIDIOFUNGIN, A UNIQUE ANTIFUNGAL GLYCOPEPTIDE PRODUCED BY A STRAIN OF BURKHOLDERIA CONTAMINANS | MISSISSIPPI STATE UNIVERSITY (US) | 2010-12-02 | — | — | WO | disclosed |
| US-6465432-B1 | PROTEOLYTIC CLEAVAGE OF PROTEINS; FOOD SUPPLEMENTS OF AMINO ACID SEQ ID NO:1-5 | KRAFT FOOD HOLDINGS, INC. | 2002-10-15 | — | — | US | disclosed |
| EP-1188767-A1 | Isolated antioxidant peptides from casein and methods for preparing, isolating and identifying antioxidant peptides | KRAFT FOODS HOLDINGS, INC. (US) | 2002-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136729-A1 | Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans | OGA, ENGASE, ST3GAL3 | KMT2A 4535/4885KDM4E 4339/4885MAPT 4604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.